Message #18 From:
NewsBot Date: January 3, 2007 06:00:00 AM
ACAD News ACADIA Pharmaceuticals to Present at the 25th Annual JP Morgan Healthcare Conference on January 11, 2007
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company
utilizing innovative technology to fuel drug discovery and clinical
development of novel treatments for central nervous system disorders,
today announced that it will present at the 25th Annual JP Morgan
Healthcare Conference on Thursday, January 11, 2007, at 1:00 p.m.
Pacific Time at The Westin St. Francis Hotel in San Francisco.
A live webcast of ACADIA’s presentation will
be accessible on the company’s website, www.acadia-pharm.com,
under the investors section and an archived recording will be available
on the website through January 25, 2007.
ACADIA is a biopharmaceutical company utilizing innovative technology to
fuel drug discovery and clinical development of novel treatments for
central nervous system disorders. ACADIA currently has five clinical
programs as well as a portfolio of preclinical and discovery assets
directed at large unmet medical needs, including schizophrenia, Parkinson’s
disease psychosis, sleep maintenance insomnia, and neuropathic pain. All
of the drug candidates in ACADIA’s product
pipeline emanate from discoveries made using its proprietary drug
discovery platform. ACADIA’s corporate
headquarters is located in San Diego, California and it maintains
research and development operations in both San Diego and Malmö,
Sweden.
